Circular Knotted Peptides From Plants: Antimicrobial Activity and Structure-Activity Rules
Four macrocyclic cystine-knot peptides from plants showed antimicrobial activity, and synthetic analogs revealed that the intact circular backbone and disulfide knot are essential for both structure and bioactivity.
Quick Facts
What This Study Found
Macrocyclic cystine-knot peptides showed antimicrobial activity requiring both the intact circular backbone and disulfide knot; disrupting either eliminated structure and biological activity.
Key Numbers
How They Did This
In-vitro study testing 4 natural macrocyclic peptides and 10 synthetic analogs against bacteria and fungi. Structural requirements assessed by systematically disrupting backbone cyclization and disulfide bonds.
Why This Research Matters
Knowing which structural features are essential for cyclotide activity guides drug design. The requirement for both circular backbone and knotted disulfides confirms the extraordinary stability is directly linked to biological function.
The Bigger Picture
Cyclotides' integrated structure-function relationship makes them ideal drug scaffolds. The stability comes from the same features that enable activity, meaning engineered cyclotides will inherit both properties automatically.
What This Study Doesn't Tell Us
Limited antimicrobial spectrum tested. The physiological function of these peptides in plants remains undetermined. Synthetic modifications were limited to backbone and disulfide disruptions.
Questions This Raises
- ?Can active sequences from other drugs be grafted into the cyclotide scaffold?
- ?What is the mechanism of cyclotide antimicrobial action?
- ?Can cyclotides be produced at scale for pharmaceutical use?
Trust & Context
- Key Stat:
- Both features required Neither the circular backbone alone nor the disulfide bonds alone are sufficient — both must be intact for cyclotide structure and antimicrobial activity
- Evidence Grade:
- Moderate evidence from a systematic structure-activity study using natural and synthetic peptides, providing clear design rules.
- Study Age:
- Published in 1999. Cyclotide drug design has advanced significantly, with the structure-activity rules described here guiding scaffold engineering efforts.
- Original Title:
- An unusual structural motif of antimicrobial peptides containing end-to-end macrocycle and cystine-knot disulfides.
- Published In:
- Proceedings of the National Academy of Sciences of the United States of America, 96(16), 8913-8 (1999)
- Database ID:
- RPEP-00567
Evidence Hierarchy
Frequently Asked Questions
What makes cyclotides special for drug design?
Their circular backbone with knotted disulfide bonds makes them extraordinarily stable. This study proves these features are also essential for antimicrobial activity, meaning stability and function come as a package.
Could cyclotides replace antibiotics?
They're being explored as alternatives. Their unique structure makes them resistant to bacterial defense mechanisms, and their stability means they could potentially be taken orally — addressing two major challenges in antimicrobial peptide development.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00567APA
Tam, J P; Lu, Y A; Yang, J L; Chiu, K W. (1999). An unusual structural motif of antimicrobial peptides containing end-to-end macrocycle and cystine-knot disulfides.. Proceedings of the National Academy of Sciences of the United States of America, 96(16), 8913-8.
MLA
Tam, J P, et al. "An unusual structural motif of antimicrobial peptides containing end-to-end macrocycle and cystine-knot disulfides.." Proceedings of the National Academy of Sciences of the United States of America, 1999.
RethinkPeptides
RethinkPeptides Research Database. "An unusual structural motif of antimicrobial peptides contai..." RPEP-00567. Retrieved from https://rethinkpeptides.com/research/tam-1999-an-unusual-structural-motif
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.